Massive layoff round will happen in 2H 2018

Quote
Where is the #MeToo movement in Denmark. We have a member of the ET of the company who has been abusing his position for years and having sexual relations with multiple women. What does the CEO have to say? NN values dont seem to come in the way of Mads. Nothing but an abuse of power.
 




anonymous said:
Where is the #MeToo movement in Denmark. We have a member of the ET of the company who has been abusing his position for years and having sexual relations with multiple women. What does the CEO have to say? NN values dont seem to come in the way of Mads. Nothing but an abuse of power.
Click to expand...
Why don’t you out him then and start it?!!?
 




anonymous said:
Most, if not all, folks in haemophilia research will be laid off. End of an era. Sad...
Click to expand...
Management has started to look at Global Blood Therapeutics (NASDAQ:GBT) as an acquisition target. That was also the case almost two years ago but they were not willing to pay up back then.

After the failed Ablynx acquisition late last year and the impending collapse of the haemophilia business following Roche's approval of Hemlibra in both inhibitor and non-inhibitor patients, the level of desperation has increased to flabbergasting levels. Due diligence is said to be well underway and management seems to be willing to run the risk that GBT's treatment of sickle cell disease may not be approved by the FDA https://endpts.com/positive-pivotal...in-search-of-a-quick-ok-for-sickle-cell-drug/
 




NNinsider said:
Management has started to look at Global Blood Therapeutics (NASDAQ:GBT) as an acquisition target. That was also the case almost two years ago but they were not willing to pay up back then.

After the failed Ablynx acquisition late last year and the impending collapse of the haemophilia business following Roche's approval of Hemlibra in both inhibitor and non-inhibitor patients, the level of desperation has increased to flabbergasting levels. Due diligence is said to be well underway and management seems to be willing to run the risk that GBT's treatment of sickle cell disease may not be approved by the FDA https://endpts.com/positive-pivotal...in-search-of-a-quick-ok-for-sickle-cell-drug/
Click to expand...

We’ve already acquired this product.
 








NNinsider said:
Management has started to look at Global Blood Therapeutics (NASDAQ:GBT) as an acquisition target. That was also the case almost two years ago but they were not willing to pay up back then.

After the failed Ablynx acquisition late last year and the impending collapse of the haemophilia business following Roche's approval of Hemlibra in both inhibitor and non-inhibitor patients, the level of desperation has increased to flabbergasting levels. Due diligence is said to be well underway and management seems to be willing to run the risk that GBT's treatment of sickle cell disease may not be approved by the FDA https://endpts.com/positive-pivotal...in-search-of-a-quick-ok-for-sickle-cell-drug/
Click to expand...
Will be like kicking the R&D haemophilia folks, who have just been laid off, in the head after having punched them to the ground.

I don't believe anyone in senior management can be that stupid and arrogant, after all.
 




anonymous said:
... and this must be the only reason why he didn't terminate Jesper Brandgaard when he had the chance last year.

To give a detail-obsessed micro manager like Jesper B. the responsibility to get biopharm back to growth is a complete joke. He'll strangle the biopharm organisation with additional reporting requirements - so that he feels in control - whilst rejecting acquisition opportunities because he is dead scared of a potential future write off.
Click to expand...
... and never say never, finally Lars F found the nerve to kick out Jesper Brandgaard. Although he won't leave officially until April '19 the signal is so positive that this arrogant, short-term focused micro manager won't be allowed to stay as member of Executive Management.

Thank you so much, Lars F. You're are our hero.
 




anonymous said:
Where is the #MeToo movement in Denmark. We have a member of the ET of the company who has been abusing his position for years and having sexual relations with multiple women. What does the CEO have to say? NN values dont seem to come in the way of Mads. Nothing but an abuse of power.
Click to expand...
MKT is now banging a new woman from the company. This time it's even juicier (if one can say so): Ulla Grove Sidelmann, UGS, is a Corporate Vice President in Biopharm production. Not bad looking according to the phone book but how is it that normal rules of conflict of "interest" (sorry for the pun) and values don't seem apply to a member of Executive Management?

#MKTrocks #metoo
 




My Manager (which for almost 2 decades was a co-worker) has told me that I would be ahead of the game to start looking after the first of the year. I had a great year but the margins are simply not there. Goo luck everyone!
 








anonymous said:
My Manager (which for almost 2 decades was a co-worker) has told me that I would be ahead of the game to start looking after the first of the year. I had a great year but the margins are simply not there. Goo luck everyone!
Click to expand...

Your manager may be giving you some good advice, but don’t read into it that he knows anything. Doug and Dave have made a point to be secretive about everything they do right up until the last minute. Management is not consulted about any changes, nor are they told in advance of anything. They find out at the same time you do.
 




anonymous said:
Your manager may be giving you some good advice, but don’t read into it that he knows anything. Doug and Dave have made a point to be secretive about everything they do right up until the last minute. Management is not consulted about any changes, nor are they told in advance of anything. They find out at the same time you do.
Click to expand...

Is that supposed to make us feel better? What happened to being transparent? ET keeping managers in the dark too? How are they making decisions without knowing what’s going on in given territories? This does not make me feel better, it makes me feel worse. Make some feel like they really have no idea what’s going on and don’t care to. How sad.
 




Some members of management are being left out in the cold while others are being consulted on a lay-off strategy. Don’t assume just because you may not know that it is hush-hush throughout the company.
 












Top Bottom
Back
Quote